ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

6,924Medicare Part D Prescriptions Filled, Including Refills

Rank: 161 out of 1269

$418K Total Retail Price of All Prescriptions

Rank: 212 out of 1269

362 Patients Receiving at Least One Drug in Part D
75%Patients 65 Years and Older
63% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maryland
Lower avg

Schedule Two
Controlled Substances

15% of this provider’s 362 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

6% of this provider’s 362 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

1% of this provider’s 4,884 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maryland
PRAVASTATIN SODIUM 209 156 1 11
LEVOTHYROXINE SODIUM 206 154 2 4
FUROSEMIDE 189 161 3 5
LISINOPRIL 168 112 4 1
METOPROLOL TARTRATE 158 125 5 6
AMLODIPINE BESYLATE 145 135 6 2
CITALOPRAM HBR 137 126 7 21
HYDROCHLOROTHIAZIDE 121 77 8 10
ZOLPIDEM TARTRATE 119 74 9 19
METFORMIN HCL 115 80 10 9
WARFARIN SODIUM 108 76 11 12
OXYCODONE HCL 101 43 S2 12 34
SIMVASTATIN 99 78 13 3
METOPROLOL SUCCINATE 98 67 14 13
PANTOPRAZOLE SODIUM 91 54 15 18
OMEPRAZOLE 88 72 16 8
ATORVASTATIN CALCIUM 83 69 17 7
MIRTAZAPINE 82 82 18 24
DONEPEZIL HCL 77 77 19 22
METFORMIN HCL ER 75 56 20 80
METHYLPREDNISOLONE 73 43 21 154
SERTRALINE HCL 70 41 22 23
CLOPIDOGREL 69 57 23 32
NEXIUM 65 29 24 41
TRAZODONE HCL 64 54 25 36
LANTUS 62 19 26 39
ATENOLOL 60 42 27 14
GABAPENTIN 59 32 28 17
OXYCODONE-ACETAMINOPHEN 56 46 S2 29 44
PROAIR HFA 56 33 29 61
PLAVIX 55 42 31 47
DIOVAN 54 39 32 35
INSULIN SYRINGE 54 27 32 87
TRAMADOL HCL 52 50 34 16
RANITIDINE HCL 51 25 35 27
TAMSULOSIN HCL 50 32 36 31
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 13, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.